The fight against cancer is an ongoing endeavor, with researchers constantly seeking novel compounds and pathways to develop more effective therapies. Ethyl 7-Chloro-2-Oxoheptanoate (CAS 78834-75-0) has emerged as a significant chemical in this critical area, contributing to the synthesis of promising anti-cancer agents.


This advanced chemical is specifically employed in cancer drug research, playing a role in the synthesis of targeted therapies, such as BCL-XL inhibitors. These inhibitors are crucial in inducing apoptosis (programmed cell death) in cancer cells, offering a pathway for highly selective and potent new treatments. For researchers focused on drug discovery, having access to a high-quality research chemical like Ethyl 7-Chloro-2-Oxoheptanoate is paramount for reliable and reproducible experimental outcomes.


The purity and consistency of such a compound are non-negotiable in scientific investigations. Ningbo Inno Pharmchem Co.,Ltd. understands the stringent requirements of oncology research and provides Ethyl 7-Chloro-2-Oxoheptanoate that meets high industry standards. While specific pricing can vary based on quantity and market conditions, Ningbo Inno Pharmchem Co.,Ltd. strives to offer competitive Ethyl 7-Chloro-2-Oxoheptanoate price to support groundbreaking studies globally. Partnering with a trusted supplier is crucial for advancing the next generation of cancer therapies, ensuring researchers have the reliable materials needed to push the boundaries of medical science.